Peter Ambrose Lander
9Patents
4h-index
47Co-inventors
49Inventor score
Filing activity: Mar 27, 2002 → May 22, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7863302B2 | Compounds and methods for modulating FX-receptors | Chemistry; Metallurgy | 17 | Active |
| US7846960B2 | FXR agonists | Chemistry; Metallurgy | 15 | Active |
| US6670373B1 | Compounds and method for inhibiting MRP1 | Human Necessities | 12 | Expired |
| US7250442B2 | Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators | Chemistry; Metallurgy | 6 | Expired |
| US8106077B2 | Compounds and methods for modulating FXR | Chemistry; Metallurgy | 4 | Active |
| US7470705B2 | Compounds and methods for treating dyslipidemia | Chemistry; Metallurgy | 3 | Expired |
| US6743794B2 | Methods and compounds for inhibiting MRP1 | Human Necessities | 2 | Expired |
| US6673809B2 | Tricyclic compounds as MRP1-inhibitors | Human Necessities | 0 | Expired |
| US7064131B2 | Compounds and methods for inhibiting MRP1 | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.